| Literature DB >> 27616863 |
Rani Somani1, Iram Zaidi2, Shipra Jaidka3.
Abstract
Platelet rich plasma (PRP) has been a breakthrough in the stimulation and acceleration of tissue healing. It represents a relatively new approach in regenerative procedures and is a developing area in pediatric dentistry. It is an autologous source of growth factors obtained by sequestrating and concentrating platelets by gradient density centrifugation. This novel and potentially promising technique enhances body's natural wound healing mechanism. This article goes on to describe preparation and clinical benefits of PRP in pediatric dentistry.Entities:
Keywords: Growth factor; PRP; Regeneration; Wound healing.
Year: 2011 PMID: 27616863 PMCID: PMC4999642 DOI: 10.5005/jp-journals-10005-1085
Source DB: PubMed Journal: Int J Clin Pediatr Dent ISSN: 0974-7052
Table 1: Summary of growth factors released from platelets
| PDGF | Cationic polypeptide (Mr = 30 kda) | Platelets, macrophages, monocytes, endothelial cells, smooth muscle cells. | Fibroblasts, smooth muscle cells, glial cells, macro-phages/neutrophils. | Stimulates chemotaxis/mitogen-esis in fibroblast/glial/smooth muscle cells; regulates collage-nase secretion/collagen synthesis; stimulates macrophage/neutrophil chemotaxis. | |||||
| TGF-b | 2-chain polypeptide (Mr = 25 kda); 3 different gene products in humans: TGF-P1, TGF-P2, TGF-P3 | Platelets, T-lymphocytes, macrophages/monocytes, neutrophils. | Fibroblasts, marrow stem cells, endothelial cells, epithelial cells, preosteoblasts. | Stimulates/inhibits endothelial, fibroblastic, and osteoblastic mitogenesis; regulates collagen synthesis/collagenase secretion; regulates mitogenic effects of other growth factors; stimulates endothelial chemotaxis and angio-genesis. | |||||
| PDEGF | 53-amino acid poly-peptide (Mr = 6 kda) | Platelets, macrophages, monocytes. | Fibroblasts, endothelial cells, epithelial cells. | Stimulates endothelial chemo-taxis/angiogenesis; regulates collagenase secretion; stimulates epithelial/mesenchymal mitogen-esis. | |||||
| PDAF | Acidic polypeptide | Platelets, endothelial cells. | Endothelial cells | Increases angiogenesis and vessel permeability; stimulates mito-genesis for endothelial cells by direct or indirect actions; several cytokines and growth factors up-regulate PDAF, including IGF-1, TGF-alpha and beta, PDGF, | |||||
| IGF-1 | Single-chain polypeptide (Mr = 47 kda) 47% homology with insulin. | Osteoblasts, macro-phages, monocytes, chondrocytes. | Fibroblasts, osteoblasts, chondrocytes. | Stimulates cartilage growth, bone matrix formation, and replication of preosteoblasts and osteoblasts; acts as an autocrine and paracrine factor; in combination with PDGF can enhance the rate and quality of wound healing. | |||||
| PF-4 | Homotetramer (Mr = 29 kda) | Platelets | Fibroblasts, neutrophils | Chemoattractant for neutrophils and fibroblasts; potent antiheparin agent. |
PDGF - platelet-derived growth factor; TFG-b - transforming growth factor beta; PDEGF - platelet-derived epidermal growth factor; PDAF - platelet-derived angiogenesis factor; IGF-1 - insulin-like growth factor 1; PF-4 - platelet factor 4; bFGF - basic fibroblast growth factor.
Fig. 1Patient’s venous blood is drawn
Fig. 2Collected in vaccutube
Fig. 3Centrifugal machine
Fig. 4Three layers of PRP
Fig. 5Aspiration of plasma and RBC
Fig. 6Mixed with calcium chloride
Fig. 7Pulpotomy with PRP
Fig. 8Postoperative after 15 days
Fig. 9Postoperative after one month
Fig. 10Extraction socket
Fig. 11Application of PRP in extraction socket
Fig. 12After 3 days (approximation of flaps)